Hope on the horizon: promising novel therapies for necrotizing enterocolitis

Necrotizing enterocolitis (NEC) remains among the most common and devastating diseases in neonates. Despite advances in neonatal clinical care, specific treatment strategies and diagnostic modalities remain lacking. As a result, morbidity and mortality remain high. Improved understanding of the path...

Full description

Saved in:
Bibliographic Details
Published inPediatric research Vol. 88; no. Suppl 1; pp. 30 - 34
Main Authors Shelby, Rita D., Raab, Ryan, Besner, Gail E., McElroy, Steven J.
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.08.2020
Nature Publishing Group
Subjects
Gangrene
Gastrointestinal diseases
Inflammatory bowel disease
Medical treatment
Medicine
Medicine & Public Health
Necrosis
Newborn babies
Pediatric Surgery
Pediatrics
Review Article
Online AccessGet full text

Cover

More Information
Summary:Necrotizing enterocolitis (NEC) remains among the most common and devastating diseases in neonates. Despite advances in neonatal clinical care, specific treatment strategies and diagnostic modalities remain lacking. As a result, morbidity and mortality remain high. Improved understanding of the pathogenesis of NEC has the potential for improved therapeutics. Some of the areas of research leading to promising discoveries include inhibition of Toll-like receptor signaling, modulation of vascular endothelial growth factor signal pathways, defining metabolomic alterations in NEC to discover potential biomarkers, probing for genetic predispositions to NEC susceptibility, determining mechanistic relations between anemia and NEC, and microflora modulation through the use of probiotics. All of these areas may represent novel promising approaches to the prevention and treatment of NEC. This review will focus on these current and possible therapeutic perspectives.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0031-3998
1530-0447
DOI:10.1038/s41390-020-1077-1